ID   MIB2_HUMAN              Reviewed;        1013 AA.
AC   Q96AX9; A2AGM5; A2AGM6; B3KV93; B3KVF4; B3KXY1; B4DZ57; E9PGU1;
AC   E9PHQ1; F8WA73; J3KNZ7; Q7Z437; Q8IY62; Q8N786; Q8N897; Q8N8R2;
AC   Q8N911; Q8NB36; Q8NCY1; Q8NG59; Q8NG60; Q8NG61; Q8NI59; Q8WYN1;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 3.
DT   10-MAY-2017, entry version 152.
DE   RecName: Full=E3 ubiquitin-protein ligase MIB2;
DE            EC=2.3.2.27;
DE   AltName: Full=Mind bomb homolog 2;
DE   AltName: Full=Novel zinc finger protein;
DE            Short=Novelzin;
DE   AltName: Full=Putative NF-kappa-B-activating protein 002N;
DE   AltName: Full=RING-type E3 ubiquitin transferase MIB2 {ECO:0000305};
DE   AltName: Full=Skeletrophin;
DE   AltName: Full=Zinc finger ZZ type with ankyrin repeat domain protein 1;
GN   Name=MIB2; Synonyms=SKD, ZZANK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INDUCTION, INTERACTION WITH ACTIN, AND VARIANT THR-45.
RX   PubMed=14507647; DOI=10.1016/S0002-9440(10)63497-9;
RA   Takeuchi T., Heng H.H.Q., Ye C.J., Liang S.-B., Iwata J., Sonobe H.,
RA   Ohtsuki Y.;
RT   "Down-regulation of a novel actin-binding molecule, skeletrophin, in
RT   malignant melanoma.";
RL   Am. J. Pathol. 163:1395-1404(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), AND VARIANT THR-45.
RA   Takeuchi T.;
RT   "A novel zinc finger protein.";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   LEU-15.
RC   TISSUE=Lung fibroblast;
RX   PubMed=12761501; DOI=10.1038/sj.onc.1206406;
RA   Matsuda A., Suzuki Y., Honda G., Muramatsu S., Matsuzaki O.,
RA   Nagano Y., Doi T., Shimotohno K., Harada T., Nishida E., Hayashi H.,
RA   Sugano S.;
RT   "Large-scale identification and characterization of human genes that
RT   activate NF-kappaB and MAPK signaling pathways.";
RL   Oncogene 22:3307-3318(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 7; 8; 9; 10 AND 11),
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 151-1013 (ISOFORM 5),
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 292-1013 (ISOFORMS 1/2/6/7),
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 327-1013 (ISOFORM 4), AND
RP   VARIANTS LEU-15 AND THR-45.
RC   TISSUE=Brain, Heart, Spleen, Teratocarcinoma, Testis, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 252-1013 (ISOFORMS 1/2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORMS 10 AND 8), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination
CC       of Delta receptors, which act as ligands of Notch proteins.
CC       Positively regulates the Delta-mediated Notch signaling by
CC       ubiquitinating the intracellular domain of Delta, leading to
CC       endocytosis of Delta receptors. {ECO:0000250|UniProtKB:Q8R516}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with actin monomer.
CC       {ECO:0000269|PubMed:14507647}.
CC   -!- INTERACTION:
CC       Q9UHD2:TBK1; NbExp=2; IntAct=EBI-2130249, EBI-356402;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14507647}.
CC       Endosome {ECO:0000269|PubMed:14507647}. Note=Colocalizes with
CC       endosomal compartments.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=14;
CC       Name=1;
CC         IsoId=Q96AX9-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha;
CC         IsoId=Q96AX9-2; Sequence=VSP_014392;
CC       Name=3; Synonyms=Gamma;
CC         IsoId=Q96AX9-3; Sequence=VSP_014395;
CC       Name=4; Synonyms=Beta;
CC         IsoId=Q96AX9-4; Sequence=VSP_014393;
CC       Name=5;
CC         IsoId=Q96AX9-5; Sequence=VSP_014396;
CC         Note=No experimental confirmation available.;
CC       Name=10;
CC         IsoId=Q96AX9-10; Sequence=VSP_035509, VSP_014393, VSP_045186;
CC         Note=No experimental confirmation available. Contains a
CC         N-acetylmethionine at position 1. {ECO:0000244|PubMed:22814378};
CC       Name=7;
CC         IsoId=Q96AX9-7; Sequence=VSP_035508;
CC       Name=8;
CC         IsoId=Q96AX9-8; Sequence=VSP_035509, VSP_035511, VSP_035512;
CC         Note=No experimental confirmation available. Contains a
CC         N-acetylmethionine at position 1. {ECO:0000244|PubMed:22814378};
CC       Name=9;
CC         IsoId=Q96AX9-9; Sequence=VSP_035510;
CC       Name=6;
CC         IsoId=Q96AX9-6; Sequence=VSP_014394;
CC         Note=No experimental confirmation available.;
CC       Name=11;
CC         IsoId=Q96AX9-11; Sequence=VSP_046405, VSP_046406;
CC         Note=No experimental confirmation available.;
CC       Name=12;
CC         IsoId=Q96AX9-12; Sequence=VSP_046405, VSP_014393;
CC         Note=No experimental confirmation available.;
CC       Name=13;
CC         IsoId=Q96AX9-13; Sequence=VSP_046405, VSP_014395;
CC         Note=No experimental confirmation available.;
CC       Name=14;
CC         IsoId=Q96AX9-14; Sequence=VSP_046405;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal muscle, and to a lesser
CC       extent in heart, brain and kidney. {ECO:0000269|PubMed:14507647}.
CC   -!- INDUCTION: Down-regulated in many primary skin melanomas.
CC       Treatment with a demethylating agent, 5'-aza-2-deoxycytidine,
CC       restores expression, suggesting that down-regulation is the result
CC       of methylation of the gene. {ECO:0000269|PubMed:14507647}.
CC   -!- PTM: Ubiquitinated. Possibly via autoubiquitination (By
CC       similarity). {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH16490.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB82979.1; Type=Frameshift; Positions=193, 205; Evidence={ECO:0000305};
CC       Sequence=BAC03707.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC04646.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC04752.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC04952.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MIB2ID44179ch1p36.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB074480; BAB92950.1; -; mRNA.
DR   EMBL; AB064367; BAB82979.1; ALT_FRAME; mRNA.
DR   EMBL; AB076691; BAC00992.1; -; mRNA.
DR   EMBL; AB076692; BAC00993.1; -; mRNA.
DR   EMBL; AB076693; BAC00994.1; -; mRNA.
DR   EMBL; AB097000; BAC77353.1; -; mRNA.
DR   EMBL; AK091610; BAC03707.1; ALT_INIT; mRNA.
DR   EMBL; AK095914; BAC04646.1; ALT_INIT; mRNA.
DR   EMBL; AK096295; BAC04752.1; ALT_INIT; mRNA.
DR   EMBL; AK097106; BAC04952.1; ALT_INIT; mRNA.
DR   EMBL; AK098785; BAC05413.1; -; mRNA.
DR   EMBL; AK122751; BAG53705.1; -; mRNA.
DR   EMBL; AK122863; BAG53766.1; -; mRNA.
DR   EMBL; AK128167; BAG54643.1; -; mRNA.
DR   EMBL; AK302757; BAG63969.1; -; mRNA.
DR   EMBL; AL691432; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016490; AAH16490.1; ALT_INIT; mRNA.
DR   EMBL; BC037542; AAH37542.1; -; mRNA.
DR   EMBL; AL834527; CAD39183.1; -; mRNA.
DR   CCDS; CCDS41224.2; -. [Q96AX9-14]
DR   CCDS; CCDS53261.1; -. [Q96AX9-13]
DR   CCDS; CCDS53262.1; -. [Q96AX9-12]
DR   CCDS; CCDS53263.1; -. [Q96AX9-11]
DR   CCDS; CCDS53264.1; -. [Q96AX9-10]
DR   RefSeq; NP_001164157.1; NM_001170686.1. [Q96AX9-13]
DR   RefSeq; NP_001164158.1; NM_001170687.1. [Q96AX9-11]
DR   RefSeq; NP_001164159.1; NM_001170688.1. [Q96AX9-12]
DR   RefSeq; NP_001164160.1; NM_001170689.1. [Q96AX9-10]
DR   RefSeq; NP_543151.2; NM_080875.2. [Q96AX9-14]
DR   UniGene; Hs.135805; -.
DR   UniGene; Hs.593430; -.
DR   ProteinModelPortal; Q96AX9; -.
DR   SMR; Q96AX9; -.
DR   BioGrid; 126769; 22.
DR   IntAct; Q96AX9; 11.
DR   MINT; MINT-3050933; -.
DR   STRING; 9606.ENSP00000426103; -.
DR   iPTMnet; Q96AX9; -.
DR   PhosphoSitePlus; Q96AX9; -.
DR   BioMuta; MIB2; -.
DR   DMDM; 209572707; -.
DR   MaxQB; Q96AX9; -.
DR   PaxDb; Q96AX9; -.
DR   PeptideAtlas; Q96AX9; -.
DR   PRIDE; Q96AX9; -.
DR   DNASU; 142678; -.
DR   Ensembl; ENST00000355826; ENSP00000348081; ENSG00000197530. [Q96AX9-11]
DR   Ensembl; ENST00000378712; ENSP00000367984; ENSG00000197530. [Q96AX9-10]
DR   Ensembl; ENST00000505820; ENSP00000426103; ENSG00000197530. [Q96AX9-14]
DR   Ensembl; ENST00000518681; ENSP00000428264; ENSG00000197530. [Q96AX9-12]
DR   Ensembl; ENST00000520777; ENSP00000428660; ENSG00000197530. [Q96AX9-13]
DR   GeneID; 142678; -.
DR   KEGG; hsa:142678; -.
DR   UCSC; uc001agg.4; human. [Q96AX9-1]
DR   CTD; 142678; -.
DR   DisGeNET; 142678; -.
DR   GeneCards; MIB2; -.
DR   HGNC; HGNC:30577; MIB2.
DR   HPA; HPA068322; -.
DR   MIM; 611141; gene.
DR   neXtProt; NX_Q96AX9; -.
DR   OpenTargets; ENSG00000197530; -.
DR   PharmGKB; PA134924284; -.
DR   eggNOG; KOG0504; Eukaryota.
DR   eggNOG; KOG4582; Eukaryota.
DR   eggNOG; ENOG410XP18; LUCA.
DR   GeneTree; ENSGT00790000122981; -.
DR   HOGENOM; HOG000231158; -.
DR   HOVERGEN; HBG068386; -.
DR   InParanoid; Q96AX9; -.
DR   KO; K10645; -.
DR   OMA; ATCGGHY; -.
DR   OrthoDB; EOG091G00Z0; -.
DR   PhylomeDB; Q96AX9; -.
DR   TreeFam; TF324147; -.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q96AX9; -.
DR   SIGNOR; Q96AX9; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; MIB2; human.
DR   GeneWiki; MIB2_(gene); -.
DR   GenomeRNAi; 142678; -.
DR   PRO; PR:Q96AX9; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000197530; -.
DR   ExpressionAtlas; Q96AX9; baseline and differential.
DR   Genevisible; Q96AX9; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005769; C:early endosome; IEA:Ensembl.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IEA:Ensembl.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004871; F:signal transducer activity; IMP:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:Ensembl.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; EXP:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 1.25.40.20; -; 4.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR010606; Mib_Herc2.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR000433; Znf_ZZ.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF06701; MIB_HERC2; 2.
DR   Pfam; PF00569; ZZ; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 9.
DR   SMART; SM00184; RING; 2.
DR   SMART; SM00291; ZnF_ZZ; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 5.
DR   PROSITE; PS51416; MIB_HERC2; 2.
DR   PROSITE; PS50089; ZF_RING_2; 2.
DR   PROSITE; PS01357; ZF_ZZ_1; 1.
DR   PROSITE; PS50135; ZF_ZZ_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Alternative splicing; ANK repeat;
KW   Complete proteome; Cytoplasm; Endosome; Metal-binding;
KW   Notch signaling pathway; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1   1013       E3 ubiquitin-protein ligase MIB2.
FT                                /FTId=PRO_0000055947.
FT   DOMAIN       59    138       MIB/HERC2 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00749}.
FT   DOMAIN      207    285       MIB/HERC2 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00749}.
FT   REPEAT      522    551       ANK 1.
FT   REPEAT      555    584       ANK 2.
FT   REPEAT      588    617       ANK 3.
FT   REPEAT      621    653       ANK 4.
FT   REPEAT      657    686       ANK 5.
FT   REPEAT      691    721       ANK 6.
FT   REPEAT      725    754       ANK 7.
FT   REPEAT      758    786       ANK 8.
FT   REPEAT      827    856       ANK 9.
FT   ZN_FING     143    190       ZZ-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00228}.
FT   ZN_FING     890    925       RING-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   ZN_FING     969   1002       RING-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   MOD_RES     309    309       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1    159       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035508.
FT   VAR_SEQ       1     58       Missing (in isoform 8 and isoform 10).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035509.
FT   VAR_SEQ       1      1       M -> MAGALRRGRALGSRPSGPTVSSRRSPQCPVAQEGLG
FT                                ARSRPRVAPRSLARCGPSSRLM (in isoform 11,
FT                                isoform 12, isoform 13 and isoform 14).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046405.
FT   VAR_SEQ      37     50       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12761501,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_014392.
FT   VAR_SEQ      42     55       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046406.
FT   VAR_SEQ     234    298       Missing (in isoform 4, isoform 10 and
FT                                isoform 12).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_014393.
FT   VAR_SEQ     347    382       Missing (in isoform 6). {ECO:0000305}.
FT                                /FTId=VSP_014394.
FT   VAR_SEQ     347    350       Missing (in isoform 3 and isoform 13).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_014395.
FT   VAR_SEQ     383    417       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_014396.
FT   VAR_SEQ     673   1013       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035510.
FT   VAR_SEQ     853   1013       ERQAGGGAAPGPRQTLGTPNTVTNLHVGAAPGPEAAECLVC
FT                                SELALLVLFSPCQHRTVCEECARRMKKCIRCQVVVSKKLRP
FT                                DGSEVASAAPAPGPPRQLVEELQSRYRQMEERITCPICIDS
FT                                HIRLVFQCGHGACAPCGSALSACPICRQPIRDRIQIFV ->
FT                                VRAQDEEVHQVPGGRQQETAPRRL (in isoform 10).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045186.
FT   VAR_SEQ     858    860       GGA -> RGR (in isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035511.
FT   VAR_SEQ     861   1013       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035512.
FT   VARIANT      15     15       F -> L (in dbSNP:rs7418389).
FT                                {ECO:0000269|PubMed:12761501,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_046668.
FT   VARIANT      45     45       M -> T (in dbSNP:rs12755088).
FT                                {ECO:0000269|PubMed:14507647,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_046669.
FT   CONFLICT     80     80       K -> N (in Ref. 6; AAH16490).
FT                                {ECO:0000305}.
FT   CONFLICT    176    177       CY -> SN (in Ref. 2; BAB82979).
FT                                {ECO:0000305}.
FT   CONFLICT    221    221       V -> A (in Ref. 2; BAB82979).
FT                                {ECO:0000305}.
FT   CONFLICT    226    226       D -> F (in Ref. 3; BAC77353).
FT                                {ECO:0000305}.
FT   CONFLICT    235    235       G -> R (in Ref. 4; BAG63969).
FT                                {ECO:0000305}.
FT   CONFLICT    273    273       H -> Y (in Ref. 6; AAH37542).
FT                                {ECO:0000305}.
FT   CONFLICT    375    375       F -> L (in Ref. 4; BAC04646).
FT                                {ECO:0000305}.
FT   CONFLICT    508    508       D -> G (in Ref. 6; AAH37542).
FT                                {ECO:0000305}.
FT   CONFLICT    637    637       S -> G (in Ref. 6; AAH37542).
FT                                {ECO:0000305}.
FT   CONFLICT    689    689       K -> E (in Ref. 4; BAC04752).
FT                                {ECO:0000305}.
FT   CONFLICT    692    692       G -> D (in Ref. 4; BAG53705).
FT                                {ECO:0000305}.
FT   CONFLICT    937    937       S -> F (in Ref. 4; BAC04646).
FT                                {ECO:0000305}.
FT   CONFLICT    975    975       S -> R (in Ref. 3; BAC77353).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1013 AA;  109939 MW;  737BA12300091C70 CRC64;
     MGWKPSEARG QSQSFQASGL QPRSLKAARR ATGRPDRSRA ARPTMDPSAH RSRAAPPNMD
     PDPQAGVQVG MRVVRGVDWK WGQQDGGEGG VGTVVELGRH GSPSTPDRTV VVQWDQGTRT
     NYRAGYQGAH DLLLYDNAQI GVRHPNIICD CCKKHGLRGM RWKCRVCLDY DLCTQCYMHN
     KHELAHAFDR YETAHSRPVT LSPRQGLPRI PLRGIFQGAK VVRGPDWEWG SQDGGEGKPG
     RVVDIRGWDV ETGRSVASVT WADGTTNVYR VGHKGKVDLK CVGEAAGGFY YKDHLPRLGK
     PAELQRRVSA DSQPFQHGDK VKCLLDTDVL REMQEGHGGW NPRMAEFIGQ TGTVHRITDR
     GDVRVQFNHE TRWTFHPGAL TKHHSFWVGD VVRVIGDLDT VKRLQAGHGE WTDDMAPALG
     RVGKVVKVFG DGNLRVAVAG QRWTFSPSCL VAYRPEEDAN LDVAERAREN KSSLSVALDK
     LRAQKSDPEH PGRLVVEVAL GNAARALDLL RRRPEQVDTK NQGRTALQVA AYLGQVELIR
     LLLQARAGVD LPDDEGNTAL HYAALGNQPE ATRVLLSAGC RADAINSTQS TALHVAVQRG
     FLEVVRALCE RGCDVNLPDA HSDTPLHSAI SAGTGASGIV EVLTEVPNID VTATNSQGFT
     LLHHASLKGH ALAVRKILAR ARQLVDAKKE DGFTALHLAA LNNHREVAQI LIREGRCDVN
     VRNRKLQSPL HLAVQQAHVG LVPLLVDAGC SVNAEDEEGD TALHVALQRH QLLPLVADGA
     GGDPGPLQLL SRLQASGLPG SAELTVGAAV ACFLALEGAD VSYTNHRGRS PLDLAAEGRV
     LKALQGCAQR FRERQAGGGA APGPRQTLGT PNTVTNLHVG AAPGPEAAEC LVCSELALLV
     LFSPCQHRTV CEECARRMKK CIRCQVVVSK KLRPDGSEVA SAAPAPGPPR QLVEELQSRY
     RQMEERITCP ICIDSHIRLV FQCGHGACAP CGSALSACPI CRQPIRDRIQ IFV
//
